BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Colloca G, Venturino A, Governato I. End points of clinical trials in metastatic castration-resistant prostate cancer: A systematic review. World J Methodol 2014; 4(2): 123-132 [PMID: 25332911 DOI: 10.5662/wjm.v4.i2.123]
URL: https://www.wjgnet.com/2222-0682/full/v4/i2/123.htm
Number Citing Articles
1
William K. Oh, Raymond Miao, Francis Vekeman, Jennifer Sung, Wendy Y. Cheng, Marjolaine Gauthier-Loiselle, Ravinder Dhawan, Mei Sheng Duh. Real-world Characteristics and Outcomes of Patients With Metastatic Castration-resistant Prostate Cancer Receiving Chemotherapy Versus Androgen Receptor-targeted Therapy After Failure of First-line Androgen Receptor-targeted Therapy in the Community SettingClinical Genitourinary Cancer 2018; 16(1): 50 doi: 10.1016/j.clgc.2017.06.004